Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed Nov 7, 2011 · 10-Q · 38 days after period end · 0000950123-11-096010
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $13.05M | $12.19M |
| Net Income | $1.85M | $1.01M |
| EPS Diluted | $0.09 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 7, 2011 · 38 d after period end
